Drug use problems with self-injected low-molecular-weight heparins in primary care Seraina MengiardiDimitrios A. TsakirisKurt E. Hersberger Clinical Trial 24 November 2010 Pages: 109 - 120
NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption Sang-Heon KimSang-Hoon KimYoung Koo Jee Pharmacogenetics 13 October 2010 Pages: 121 - 127
Effect of ABCG2 genotypes on the pharmacokinetics of A771726, an active metabolite of prodrug leflunomide, and association of A771726 exposure with serum uric acid level Kyoung-Ah KimHyun-Jin JooJi-Young Park Pharmacogenetics 23 October 2010 Pages: 129 - 134
Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort Jolanta Majcher-PeszynskaMarko Sassfor the Moxifloxacin-DFI Study Group Pharmacokinetics and Disposition 25 September 2010 Pages: 135 - 142
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients Leonardo CalzaLaura MoscaPierluigi Viale Pharmacokinetics and Disposition 28 September 2010 Pages: 143 - 149
The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukast Tiina KaronenPertti J. NeuvonenJanne T. Backman Pharmacokinetics and Disposition 08 October 2010 Pages: 151 - 155
Regulatory scientific advice in drug development: does company size make a difference? Michelle PutzeistAukje K. Mantel-TeeuwisseHubert G. Leufkens Pharmacoepidemiology and Prescription Open access 04 November 2010 Pages: 157 - 164
Trends in opioid analgesics consumption, Israel, 2000–2008 Alexander M. PonizovskyEli MaromNathan I. Cherny Pharmacoepidemiology and Prescription 06 November 2010 Pages: 165 - 168
Antidepressant utilization patterns and mortality in Swedish men and women aged 20–34 years Karolina Andersson SundellMika GisslerMargda Waern Pharmacoepidemiology and Prescription 10 November 2010 Pages: 169 - 178
Pharmacists’ views on integrated electronic prescribing systems: associations between usefulness, pharmacological safety, and barriers to technology use Bahlol RahimiToomas Timpka Pharmacoepidemiology and Prescription 11 November 2010 Pages: 179 - 184
Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors E. PappaN. KontodimopoulosD. Niakas Pharmacoepidemiology and Prescription 11 November 2010 Pages: 185 - 192
Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway Helle HåkonsenElse-Lydia Toverud Pharmacoeconomics Open access 16 December 2010 Pages: 193 - 201
Consumption of non-steroidal anti-inflammatory drugs in Serbia: a comparison with Croatia and Denmark during 2005–2008 Vesna MijatovićJelena ĆalasanVukašin Radulović Short Communication 24 November 2010 Pages: 203 - 207
Emergence delirium after propofol anaesthesia Ulrich PalmJohanna GeigerMartin Lieb Letter to the Editors 28 September 2010 Pages: 209 - 210
Linkage disequilibrium between the CYP2C19*17 and CYP2C8*2 alleles in populations of African descent Guilherme Suarez-Kurtz Letter to the Editors 03 October 2010 Pages: 211 - 212
Is exogenous administration of IL-1ra (anakinra) likely to induce severe depression? Annie Pierre Jonville-BeraJean-Louis GuilmotJulie Magnant Letter to the Editors 13 October 2010 Pages: 213 - 214